Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance.

@article{Stoops2008SafetyTA,
  title={Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance.},
  author={William W. Stoops and John W. T. Blackburn and David A Hudson and Lon R. Hays and Craig R Rush},
  journal={Drug and alcohol dependence},
  year={2008},
  volume={92 1-3},
  pages={
          282-5
        }
}
The results of recent research indicate that agonist replacement may be a viable option in the treatment of cocaine dependence. For example, d-amphetamine and modafinil have shown promise in managing cocaine dependence in preliminary clinical trials. The aim of this study was to determine the physiological and subject-rated effects of acute intranasal cocaine doses during chronic atomoxetine treatment. Atomoxetine was chosen because it produces pharmacological and subject-rated effects similar… 
Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.
TLDR
The physiological and behavioral effects of cocaine during D-amphetamine maintenance in seven cocaine-dependent participants are determined, further suggesting that agonist replacement therapy may be a viable strategy for managing cocaine abuse.
Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance
TLDR
The results suggest that methamphetamine can be safely administered to participants maintained on atomoxetine, but whether it might be an effective pharmacotherapy for methamphetamine dependence remains to be determined.
Safety of Atomoxetine in Combination With Intravenous Cocaine in Cocaine-Experienced Participants
TLDR
Certain cognitive improvements and a dampening effect on VAS scores after cocaine were observed, but should be weighed against small but significant differences in hemodynamic responses after atomoxetine.
Cocaine Choice in Humans During d-Amphetamine Maintenance
TLDR
The results are concordant with those of previous preclinical experiments, human laboratory studies, and clinical trials that suggest that agonist replacement therapy may be a viable strategy for managing cocaine dependence.
Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans.
TLDR
It is demonstrated that intranasal cocaine functions as a reinforcer under a progressive ratio schedule in humans and may be useful for examining the influence of putative pharmacological and behavioral interventions on intranAsal cocaine self-administration.
Selective Norepinephrine Reuptake Inhibition by Atomoxetine Prevents Cue-Induced Heroin and Cocaine Seeking
TLDR
Selective norepinephrine transporter inhibition by ATO might be an effective treatment for the prevention of relapse to both stimulant and opiate addiction.
Atomoxetine in abstinent cocaine users: Cognitive, subjective and cardiovascular effects
TLDR
Atomoxetine has been proposed as a pharmacotherapy for cocaine use disorder (CUD) and shows potential as a treatment for CUD based on its efficacy as a cognitive enhancer in other clinical populations and impact on addictive processes in preclinical and human laboratory studies.
Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trial.
TLDR
The data provide no support for the utility of atomoxetine in the treatment of cocaine dependence and the drug was generally well tolerated in this population.
Atomoxetine Attenuates Dextroamphetamine Effects in Humans
TLDR
Atomoxetine's capacity to attenuate some of the physiological and subjective responses to dextroamphetamine supports its potential use for stimulant addiction.
Drugs currently in Phase II clinical trials for cocaine addiction
TLDR
The efficacy of topiramate was closely associated with regular cognitive-behavioural therapy (CBT), which highlights the importance of a combined effort to promote abstinence and enhance retention via CBT, and their utility in terms of bioavailability and half-life.
...
1
2
3
4
...

References

SHOWING 1-10 OF 22 REFERENCES
Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine.
TLDR
It is predicted that atomoxetine, in contrast to methylphenidate but like desipramine, will lack reinforcing effects and abuse potential in humans.
Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.
TLDR
The behavioral effects of atomoxetine overlap to a small degree with psychomotor stimulants and that it has low abuse potential, suggesting that it might be useful for the treatment of stimulant dependence.
Risperidone Attenuates the Discriminative-Stimulus Effects of d-Amphetamine in Humans
TLDR
The results of the present experiment suggest that combining drug-discrimination and self-reported drug-effect questionnaires may be an effective strategy for assessing the behavioral effects of agonist-antagonist interactions.
Dextroamphetamine for Cocaine-Dependence Treatment: A Double-Blind Randomized Clinical Trial
TLDR
A properly implemented agonist treatment regimen should improve retention and reduce illicit drug use, and the results provide support for additional examination of the agonist model in psychostimulantdependence treatment.
Evaluation of the Reinforcing Effects of Monoamine Reuptake Inhibitors Under a Concurrent Schedule of Food and I.V. Drug Delivery in Rhesus Monkeys
TLDR
The absence of reinforcing effects of atomoxetine support the view that, like desipramine, it has no evident abuse potential and is consistent with previous findings in nonhuman primates and with their documented abuse liability.
A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence
TLDR
Preliminary evidence is provided that modafinil improves clinical outcome when combined with psychosocial treatment for cocaine dependence, and should be confirmed by a larger study.
Agonist-Like or Antagonist-Like Treatment for Cocaine Dependence with Methadone for Heroin Dependence: Two Double-Blind Randomized Clinical Trials
TLDR
The results provide support for the agonist- like (d-amphetamine) model in cocaine dependence treatment but not for antagonist-like (risperidone) treatment, and coincide with previous reports of amphetamine or ris peridone administered singly in cocaine-dependent individuals.
Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users.
TLDR
The results suggest that atomoxetine does not induce subjective effects similar to methylphenidate and suggest that it is unlikely that atomxetine will have abuse liability.
An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder.
TLDR
The results of this study support additional controlled trials of atomoxetine in cases of pediatric ADHD and extend to children the positive results previously reported in adults diagnosed with ADHD who were treated with atomxetine.
Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys.
  • R. Spealman
  • Medicine
    The Journal of pharmacology and experimental therapeutics
  • 1995
TLDR
The results support a role for norepinephrine uptake and alpha-1 adrenoceptor mechanisms in the DS effects of cocaine, possibly reflecting a facilitory noradrenergic influence on mesocorticolimbic dopamine activity.
...
1
2
3
...